Circulating microRNA associated with future relapse status in major depressive disorder

Area of Science:

• Biochemistry
• Genetics
• Neuroscience

Background:

• Major depressive disorder (MDD) is characterized by recurrent episodes, necessitating biomarkers to predict relapse.
• Identifying individuals at high risk for recurrence is crucial for timely intervention and improved patient outcomes.

Purpose of the Study:

• To investigate the association between circulating microRNAs (miRNAs) and relapse risk in patients with recurrent major depressive disorder.
• To explore potential miRNA biomarkers for predicting future depressive episodes.

Main Methods:

• Serum samples from 217 participants (63 relapsers, 154 non-relapsers) in the OBSERVEMDD0001 study were analyzed for 575 circulating miRNAs using the ID3EAL™ miRNA Discovery Platform.
• miRNA levels were quantified using patented qPCR technology and normalized with spike-in controls.
• Linear models adjusted for age, gender, and plate were used to test the association between miRNAs and relapse status.

Main Results:

• Four circulating miRNAs showed nominal association with relapse status (false discovery rate adjusted p-value < 0.1).
• Enrichment analysis identified 112 significantly enriched pathways, including neurogenesis, cytokine response, and neurotrophin signaling.
• These pathways are implicated in the pathophysiology of major depressive disorder.

Conclusions:

• Specific circulating miRNAs may serve as potential biomarkers for predicting relapse in major depressive disorder.
• These miRNAs could regulate genes involved in key signaling pathways relevant to MDD.
• Further validation in larger, independent cohorts is needed to develop a predictive miRNA signature for early intervention.